Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy.

Journal: Clinical nuclear medicine
Published Date: Jan 12, 2023

Abstract

Port-site metastasis is an extremely rare complication following minimally invasive oncologic surgery for prostate cancer. We present the case of a 74-year-old man who underwent robot-assisted laparoscopic radical prostatectomy followed by salvage radiotherapy. Despite treatment, he developed biochemical recurrence. However, there was no evidence of disease on CT and bone scan at a prostate-specific antigen of 4.6 ng/mL. Subsequently, 18 F-DCFPyL PET/CT revealed a solitary focus of intense uptake in the right rectus abdominis muscle that was felt to represent a port-site metastasis. Histopathologic evaluation with immunostaining following ultrasound-guided needle biopsy confirmed the presence of metastatic adenocarcinoma of the prostate.

Authors

  • Hanan Zahed
    From the Departments of Nuclear Medicine.
  • Jerome Laufer
    From the Departments of Nuclear Medicine.
  • Martin LeBlanc
    From the Departments of Nuclear Medicine.
  • Steven Tisseverasinghe
    Radiation Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Tamim Niazi
    Radiation Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Stephan Probst
    Department of Nuclear Medicine, Jewish General Hospital, Québec, Montreal, Canada.

Keywords

External Resources

Popular Topics
Recent Journals